創薬サービス市場：プロセス、薬剤タイプ、サービスタイプ、治療領域、エンドユーザー別-2025-2030年世界予測

創薬サービス市場は、2023年に217億7,000万米ドルと評価され、2024年には247億9,000万米ドルに達すると予測され、CAGR 14.37％で成長し、2030年には557億5,000万米ドルに達すると予測されています。

創薬サービス市場はヘルスケアにおいて極めて重要であり、ターゲット同定からリード最適化まで、医薬品研究開発のさまざまな段階を通じて包括的なサポートを提供することに重点を置いています。この市場は、慢性疾患や生命を脅かす疾患を治療するための革新的な治療法に対する需要の高まりと、費用対効果の高いソリューションの必要性から不可欠なものとなっています。その用途は製薬会社、バイオテクノロジー企業、大学、研究機関にまたがり、最終用途は初期の薬剤スクリーニングから前臨床試験、臨床試験の支援まで多岐にわたる。市場の成長には、研究開発費の急増や創薬アウトソーシングの増加とともに、ハイスループットスクリーニング、バイオインフォマティクス、機械学習などの技術進歩が拍車をかけています。予測モデリングや個別化医療のためのAI統合の拡大や、共同パートナーシップを通じて医薬品開発プロセスを強化することにビジネスチャンスがあります。こうした機会を捉えるため、企業は研究機関やハイテク企業との戦略的提携の促進に注力し、最先端技術への投資を行うべきです。しかし、市場は厳しい規制要件、高額な初期設備投資、医薬品開発プロセスの複雑さといった課題に直面しています。こうした制約が迅速な成長を妨げる可能性があります。遺伝子編集のためのCRISPR技術、リアルタイムのデータ分析、改良された仮想スクリーニング手法などの分野における革新は、事業成長のための実現可能な道を示しています。市場の性質が進化するにつれて、知識やリソースの共有を促す、より共同的なプロジェクトやオープンソースプラットフォームへのシフトが目に見えています。したがって、企業は、反復学習と適応をサポートする柔軟な運営フレームワークを採用することによって、イノベーション能力を高めることを目指すべきです。企業はまた、この競合情勢で成功するために、規制の変化や市場の需要に機敏に対応し続けなければならないです。顧客ニーズと技術統合に焦点を当てることで、企業は市場の複雑性をうまく乗り切り、持続可能な成長を推進することができます。

市場力学：急速に進化する創薬サービス市場の主要市場インサイトを公開

創薬サービス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 製薬・バイオ医薬品業界における研究開発投資の拡大
  • 分析試験および臨床試験サービスのアウトソーシング需要の魅力的な高まり
  • 希少疾患と希少医薬品の調査
• 市場抑制要因
  • 高価な創薬と薬剤開発
• 市場機会
  • 生物製剤の開発と創薬への注力
  • 特許切れによる可能性
• 市場の課題
  • 創薬と動物使用に関する政府の厳しい規則

ポーターの5つの力創薬サービス市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：創薬サービス市場における外部からの影響の把握

外部マクロ環境要因は、創薬サービス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析創薬サービス市場における競合情勢の把握

創薬サービス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス創薬サービス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、創薬サービス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨創薬サービス市場における成功への道筋を描く

創薬サービス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 医薬品・バイオ医薬品業界における研究開発投資の増加
    • 分析試験および臨床試験サービスのアウトソーシング需要の魅力的な増加
    • 希少疾患と希少疾病用医薬品の調査
  • 抑制要因
    • 高額な医薬品の発見と開発
  • 機会
    • 生物製剤の開発と創薬への注力
    • 特許の失効に伴う可能性
  • 課題
    • 医薬品の発見と動物の使用に関する政府の厳しい規則
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 創薬サービス市場：プロセス別

• 候補者の検証
• ヒットからリードまでの識別
• リード最適化
• ターゲットの選択
• ターゲット検証

第7章 創薬サービス市場薬の種類別

• 生物学的製剤
• 小分子

第8章 創薬サービス市場：サービスタイプ別

• 生物学サービス
• 化学サービス

第9章 創薬サービス市場治療領域別

• 心血管疾患
• 消化器疾患
• 神経学
• 腫瘍学

第10章 創薬サービス市場：エンドユーザー別

• 学術機関
• 製薬・バイオテクノロジー企業

第11章 南北アメリカの創薬サービス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の創薬サービス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの創薬サービス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Aganitha AI Inc.
• Agilent Technologies, Inc.
• Aurigene Discovery Technologies
• BellBrook Labs
• BioAscent Discovery Ltd.
• Charles River Laboratories International, Inc.
• Domainex Ltd.
• Enzo Life Sciences Inc.
• Eurofins Scientific SE
• Frontage Laboratories, Inc.
• GenScript Biotech Corporation
• Integrated DNA Technologies, Inc.
• IQVIA Inc
• Jubilant Biosys Ltd.
• Labcorp Drug Development
• Merck KGaA
• Piramal Pharma Solutions
• Proteros biostructures GmbH
• Sai Life Sciences Limited
• Schrodinger, Inc.
• Selvita S.A.
• Shanghai ChemPartner
• Shanghai Medicilon, Inc.
• Symeres
• Syngene International Limited
• TCG Lifesciences Pvt. Limited
• Thermo Fisher Scientific Inc.
• UCB S.A.
• Viva Biotech
• Wuxi Apptec

LIST OF FIGURES

• FIGURE 1. DRUG DISCOVERY SERVICES MARKET RESEARCH PROCESS
• FIGURE 2. DRUG DISCOVERY SERVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. DRUG DISCOVERY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. DRUG DISCOVERY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DRUG DISCOVERY SERVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DRUG DISCOVERY SERVICES MARKET DYNAMICS
• TABLE 7. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CANDIDATE VALIDATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT-TO-LEAD IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET SELECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOLOGY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CHEMISTRY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY DIGESTIVE SYSTEM DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 44. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 45. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 46. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 47. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. CHINA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 71. CHINA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 72. CHINA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 73. CHINA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 74. CHINA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. INDIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 76. INDIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 77. INDIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 78. INDIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 79. INDIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 162. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 163. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 164. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 165. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 181. POLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 182. POLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 183. POLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 184. POLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 185. POLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 186. QATAR DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 187. QATAR DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 188. QATAR DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 189. QATAR DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 190. QATAR DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 236. DRUG DISCOVERY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 237. DRUG DISCOVERY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Drug Discovery Services Market was valued at USD 21.77 billion in 2023, expected to reach USD 24.79 billion in 2024, and is projected to grow at a CAGR of 14.37%, to USD 55.75 billion by 2030.

The drug discovery services market is pivotal in healthcare, focusing on providing comprehensive support through various stages of drug research and development, from target identification to lead optimization. This market is essential due to the increasing demand for innovative therapies to treat chronic and life-threatening diseases, coupled with the need for cost-effective solutions. Its applications span across pharmaceutical and biotechnology companies, universities, and research institutions, with end-use encompassing everything from initial drug screening to preclinical and clinical trial assistance. Market growth is fueled by technological advancements like high-throughput screening, bioinformatics, and machine learning, alongside a surge in R&D expenditure and an increase in drug discovery outsourcing. Opportunities lie in expanding AI integration for predictive modeling and personalized medicine, as well as enhancing the drug development process through collaborative partnerships. To seize these opportunities, companies should focus on fostering strategic alliances with research institutions and tech firms, and invest in cutting-edge technologies. However, the market faces challenges such as stringent regulatory requirements, high initial capital investments, and the complexity of drug development processes. These limitations might impede swift growth. Innovations in areas like CRISPR technology for gene editing, real-time data analytics, and improved virtual screening methods present feasible avenues for business growth. As the nature of the market evolves, there is a visible shift towards more collaborative projects and open-source platforms that encourage shared knowledge and resources. Thus, businesses should aim at enhancing their capacity for innovation by adopting flexible operational frameworks that support iterative learning and adaptation. Companies must also remain agile and responsive to regulatory changes and market demands to succeed in this competitive landscape. By focusing on customer needs and technological integration, organizations can better navigate the market's complexities and drive sustainable growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Discovery Services Market

The Drug Discovery Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing R&D investments in the pharmaceutical & biopharmaceutical industry
  • Attractive rise in demand for outsourcing analytical testing and clinical trial services
  • Research on rare diseases and orphan drugs
• Market Restraints
  • Expensive drug discovery and development
• Market Opportunities
  • Development in the biologics and focus on drug discovery
  • Potential associated with expiry of patents
• Market Challenges
  • Strict government rules for drug discovery and animal usage

Porter's Five Forces: A Strategic Tool for Navigating the Drug Discovery Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Discovery Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Discovery Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Discovery Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Discovery Services Market

A detailed market share analysis in the Drug Discovery Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Discovery Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Discovery Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug Discovery Services Market

A strategic analysis of the Drug Discovery Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Discovery Services Market, highlighting leading vendors and their innovative profiles. These include Aganitha AI Inc., Agilent Technologies, Inc., Aurigene Discovery Technologies, BellBrook Labs, BioAscent Discovery Ltd., Charles River Laboratories International, Inc., Domainex Ltd., Enzo Life Sciences Inc., Eurofins Scientific SE, Frontage Laboratories, Inc., GenScript Biotech Corporation, Integrated DNA Technologies, Inc., IQVIA Inc, Jubilant Biosys Ltd., Labcorp Drug Development, Merck KGaA, Piramal Pharma Solutions, Proteros biostructures GmbH, Sai Life Sciences Limited, Schrodinger, Inc., Selvita S.A., Shanghai ChemPartner, Shanghai Medicilon, Inc., Symeres, Syngene International Limited, TCG Lifesciences Pvt. Limited, Thermo Fisher Scientific Inc., UCB S.A., Viva Biotech, and Wuxi Apptec.

Market Segmentation & Coverage

This research report categorizes the Drug Discovery Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Process, market is studied across Candidate Validation, Hit-to-Lead Identification, Lead Optimization, Target Selection, and Target Validation.
• Based on Drug Type, market is studied across Biologics and Small Molecules.
• Based on Service type, market is studied across Biology Services and Chemistry Services.
• Based on Therapeutic Area, market is studied across Cardiovascular Diseases, Digestive System Diseases, Neurology, and Oncology.
• Based on End-user, market is studied across Academic Institutes and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing R&D investments in the pharmaceutical & biopharmaceutical industry
    • 5.1.1.2. Attractive rise in demand for outsourcing analytical testing and clinical trial services
    • 5.1.1.3. Research on rare diseases and orphan drugs
  • 5.1.2. Restraints
    • 5.1.2.1. Expensive drug discovery and development
  • 5.1.3. Opportunities
    • 5.1.3.1. Development in the biologics and focus on drug discovery
    • 5.1.3.2. Potential associated with expiry of patents
  • 5.1.4. Challenges
    • 5.1.4.1. Strict government rules for drug discovery and animal usage
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Drug Discovery Services Market, by Process

• 6.1. Introduction
• 6.2. Candidate Validation
• 6.3. Hit-to-Lead Identification
• 6.4. Lead Optimization
• 6.5. Target Selection
• 6.6. Target Validation

7. Drug Discovery Services Market, by Drug Type

• 7.1. Introduction
• 7.2. Biologics
• 7.3. Small Molecules

8. Drug Discovery Services Market, by Service type

• 8.1. Introduction
• 8.2. Biology Services
• 8.3. Chemistry Services

9. Drug Discovery Services Market, by Therapeutic Area

• 9.1. Introduction
• 9.2. Cardiovascular Diseases
• 9.3. Digestive System Diseases
• 9.4. Neurology
• 9.5. Oncology

10. Drug Discovery Services Market, by End-user

• 10.1. Introduction
• 10.2. Academic Institutes
• 10.3. Pharmaceutical & Biotechnology Companies

11. Americas Drug Discovery Services Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Drug Discovery Services Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Drug Discovery Services Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Aganitha AI Inc.
• 2. Agilent Technologies, Inc.
• 3. Aurigene Discovery Technologies
• 4. BellBrook Labs
• 5. BioAscent Discovery Ltd.
• 6. Charles River Laboratories International, Inc.
• 7. Domainex Ltd.
• 8. Enzo Life Sciences Inc.
• 9. Eurofins Scientific SE
• 10. Frontage Laboratories, Inc.
• 11. GenScript Biotech Corporation
• 12. Integrated DNA Technologies, Inc.
• 13. IQVIA Inc
• 14. Jubilant Biosys Ltd.
• 15. Labcorp Drug Development
• 16. Merck KGaA
• 17. Piramal Pharma Solutions
• 18. Proteros biostructures GmbH
• 19. Sai Life Sciences Limited
• 20. Schrodinger, Inc.
• 21. Selvita S.A.
• 22. Shanghai ChemPartner
• 23. Shanghai Medicilon, Inc.
• 24. Symeres
• 25. Syngene International Limited
• 26. TCG Lifesciences Pvt. Limited
• 27. Thermo Fisher Scientific Inc.
• 28. UCB S.A.
• 29. Viva Biotech
• 30. Wuxi Apptec